Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity

Vascular Receptor Autoantibodies in Pulmonary Arterial Hypertension Associated with Systemic Sclerosis

(2014) Mike O. Becker et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients

(2014) Jeannine Günther et al.   ARTHRITIS RESEARCH & THERAPY

Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis

(2014) Angela Kill et al.   ARTHRITIS RESEARCH & THERAPY

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

(2013) Frank van den Hoogen et al.   ANNALS OF THE RHEUMATIC DISEASES

Influence of Interstitial Lung Disease on Outcome in Systemic Sclerosis

(2013) Philippe R. Bauer et al.   CHEST

Involvement of functional autoantibodies against vascular receptors in systemic sclerosis

(2010) G. Riemekasten et al.   ANNALS OF THE RHEUMATIC DISEASES

Prevalence of Pulmonary Hypertension in Systemic Sclerosis in European Caucasians and Metaanalysis of 5 Studies

(2010) J. AVOUAC et al.   JOURNAL OF RHEUMATOLOGY

Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: Impact of interstitial lung disease

(2009) Stephen C. Mathai et al.   ARTHRITIS AND RHEUMATISM

Misclassification of Pulmonary Hypertension Due to Reliance on Pulmonary Capillary Wedge Pressure Rather Than Left Ventricular End-Diastolic Pressure

(2009) Scott D. Halpern et al.   CHEST

Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)

(2009) et al.   EUROPEAN HEART JOURNAL

Diagnosis and Assessment of Pulmonary Arterial Hypertension

(2009) David B. Badesch et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Updated Clinical Classification of Pulmonary Hypertension

(2009) Gérald Simonneau et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinerAIR-Sclerodermie study

(2009) E. Hachulla et al.   RHEUMATOLOGY

Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era

(2008) Robin Condliffe et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Systemic sclerosis and its pulmonary complications in The Netherlands: an epidemiological study

(2008) M C Vonk et al.   ANNALS OF THE RHEUMATIC DISEASES

Pulmonary hypertension in interstitial lung disease

(2008) J. Behr et al.   EUROPEAN RESPIRATORY JOURNAL

Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis

(2008) S. Phung et al.   INTERNAL MEDICINE JOURNAL

The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement

(2008) N. Hunzelmann et al.   RHEUMATOLOGY